Welcome to our annual celebration of the top development and manufacturing technologies released over the course of the year!

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.

At this time of year, we like to recognize the people and companies that have helped drive innovation and success – but we need your help.

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?